CM
IBB icon

Caption Management’s iShares Biotechnology ETF IBB Stock Holding History

Caption Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-74,000
Closed -$12.5M – 1766
2025
Q4 		$12.5M Sell
74,000
-4,500
-6% -$731K 0.09% 281
2025
Q3 		$11.3M Buy
+78,500
New +$10.7M 0.09% 248
2025
Q1 		– Sell
-2,000
Closed -$264K – 1757
2024
Q4 		$264K Hold
2,000
– – ﹤0.01% 1218
2024
Q3 		$291K Hold
2,000
– – ﹤0.01% 1016
2024
Q2 		$275K Buy
+2,000
New +$267K ﹤0.01% 916
2024
Q1 		– Sell
-3,100
Closed -$421K – 1409
2023
Q4 		$421K Buy
+3,100
New +$378K 0.01% 1005

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Caption Management's IBB Position: Q1 2026 in Review

Caption Management sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 74,000 shares — an estimated $12.5M sold.

Caption Management first reported a position in IBB in Q4 2023 and held it in 6 quarters. The position peaked at $12.5M in Q4 2025. 923 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Caption Management reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 74,000 iShares Biotechnology ETF shares in Q1 2026, an estimated $12.5M.
  • Caption Management first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 6 quarters.
  • Caption Management's iShares Biotechnology ETF position peaked at $12.5M in Q4 2025.
  • 923 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.